Common sequence variations in the P2Y 12 and CYP3A5 genes do not explain the variability in the inhibitory effects of clopidogrel therapy

Author： Smith Simon M. G. Judge Heather M. Peters Gary Armstrong Martin Fontana Pierre Gaussem Pascale Daly Martina E. Storey Robert F.

Publisher： Informa Healthcare

ISSN： 1369-1635

Source： Platelets, Vol.17, Iss.4, 2006-06, pp. : 250-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

P2Y₁₂ and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP

By Iyú David Glenn Jackie R. White Ann E. Fox Sue C. Dovlatova Natalia Heptinstall Stan

Platelets, Vol. 22, Iss. 7, 2011-11 ,pp. : 504-515

Informa Healthcare

Access to resources Recommend Favorite

Intra-individual variability of residual platelet reactivity assessed by the VerifyNow-P2Y12 assay in patients with clopidogrel resistance after percutaneous coronary intervention

By Ahn Sung Gyun Lee Seung-Hwan Sung Joong Kyung Kim Jang-Young Yoon Junghan

Platelets, Vol. 22, Iss. 4, 2011-06 ,pp. : 305-307

Informa Healthcare

Access to resources Recommend Favorite

Effects of VerifyNow P2Y12 test and CYP2C19*2 testing on clinical outcomes of patients with cardiovascular disease: A systematic review and meta-analysis

By Yamaguchi Yusuke

Platelets, Vol. 24, Iss. 5, 2013-08 ,pp. : 352-361

Informa Healthcare

Access to resources Recommend Favorite

Advances in the monitoring of anti-P2Y₁₂ therapy

By Harrison Paul

Platelets, Vol. 23, Iss. 7, 2012-11 ,pp. : 510-525

Informa Healthcare

Access to resources Recommend Favorite

Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms

By Kar Rakhee

Platelets, Vol. 24, Iss. 4, 2013-06 ,pp. : 297-302

Informa Healthcare

Access to resources Recommend Favorite